| Product Code: ETC6117778 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Antigua and Barbuda`s IVD import shipments in 2024 continued to show a high level of concentration, with the top countries exporting being the USA, UK, China, Barbados, and Trinidad and Tobago. The Herfindahl-Hirschman Index (HHI) remained at a very high level, indicating a concentrated market. The compound annual growth rate (CAGR) from 2020 to 2024 was a robust 26.82%, showcasing significant expansion in the industry. Moreover, the impressive growth rate of 35.0% from 2023 to 2024 suggests a thriving market for IVD imports in Antigua and Barbuda.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Antigua and Barbuda IVD Market Overview |
3.1 Antigua and Barbuda Country Macro Economic Indicators |
3.2 Antigua and Barbuda IVD Market Revenues & Volume, 2021 & 2031F |
3.3 Antigua and Barbuda IVD Market - Industry Life Cycle |
3.4 Antigua and Barbuda IVD Market - Porter's Five Forces |
3.5 Antigua and Barbuda IVD Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Antigua and Barbuda IVD Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.7 Antigua and Barbuda IVD Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Antigua and Barbuda IVD Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Antigua and Barbuda IVD Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Antigua and Barbuda |
4.2.2 Growing adoption of point-of-care testing solutions |
4.2.3 Government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 Lack of skilled healthcare professionals to operate IVD devices |
4.3.2 High cost associated with advanced IVD technologies |
4.3.3 Stringent regulatory requirements for IVD product approvals |
5 Antigua and Barbuda IVD Market Trends |
6 Antigua and Barbuda IVD Market, By Types |
6.1 Antigua and Barbuda IVD Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Antigua and Barbuda IVD Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Antigua and Barbuda IVD Market Revenues & Volume, By Reagents, 2021- 2031F |
6.1.4 Antigua and Barbuda IVD Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.5 Antigua and Barbuda IVD Market Revenues & Volume, By Software And Services, 2021- 2031F |
6.2 Antigua and Barbuda IVD Market, By Technique |
6.2.1 Overview and Analysis |
6.2.2 Antigua and Barbuda IVD Market Revenues & Volume, By Immunodiagnostics, 2021- 2031F |
6.2.3 Antigua and Barbuda IVD Market Revenues & Volume, By Blood Testing, 2021- 2031F |
6.2.4 Antigua and Barbuda IVD Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.2.5 Antigua and Barbuda IVD Market Revenues & Volume, By Tissue Diagnostics, 2021- 2031F |
6.2.6 Antigua and Barbuda IVD Market Revenues & Volume, By Clinical Chemistry, 2021- 2031F |
6.2.7 Antigua and Barbuda IVD Market Revenues & Volume, By Other Ivd Techniques, 2021- 2031F |
6.3 Antigua and Barbuda IVD Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Antigua and Barbuda IVD Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.3 Antigua and Barbuda IVD Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Antigua and Barbuda IVD Market Revenues & Volume, By Cardiac Diseases, 2021- 2031F |
6.3.5 Antigua and Barbuda IVD Market Revenues & Volume, By Immune System Disorders, 2021- 2031F |
6.3.6 Antigua and Barbuda IVD Market Revenues & Volume, By Nephrological Diseases, 2021- 2031F |
6.3.7 Antigua and Barbuda IVD Market Revenues & Volume, By Gastrointestinal Diseases, 2021- 2031F |
6.4 Antigua and Barbuda IVD Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Antigua and Barbuda IVD Market Revenues & Volume, By Standalone Laboratories, 2021- 2031F |
6.4.3 Antigua and Barbuda IVD Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Antigua and Barbuda IVD Market Revenues & Volume, By Academic And Medical Schools, 2021- 2031F |
6.4.5 Antigua and Barbuda IVD Market Revenues & Volume, By Point Of Care Testing, 2021- 2031F |
6.4.6 Antigua and Barbuda IVD Market Revenues & Volume, By Others End-User, 2021- 2031F |
7 Antigua and Barbuda IVD Market Import-Export Trade Statistics |
7.1 Antigua and Barbuda IVD Market Export to Major Countries |
7.2 Antigua and Barbuda IVD Market Imports from Major Countries |
8 Antigua and Barbuda IVD Market Key Performance Indicators |
8.1 Number of healthcare facilities adopting IVD technologies |
8.2 Percentage of healthcare budget allocated to IVD testing |
8.3 Rate of adoption of new IVD technologies |
8.4 Number of public health campaigns promoting IVD testing |
8.5 Level of government funding for IVD infrastructure development |
9 Antigua and Barbuda IVD Market - Opportunity Assessment |
9.1 Antigua and Barbuda IVD Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Antigua and Barbuda IVD Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.3 Antigua and Barbuda IVD Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Antigua and Barbuda IVD Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Antigua and Barbuda IVD Market - Competitive Landscape |
10.1 Antigua and Barbuda IVD Market Revenue Share, By Companies, 2024 |
10.2 Antigua and Barbuda IVD Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here